As Chevron (CVX) Stock Value Declined, Shareholder First Financial Has Cut Position; Armstrong Henry H Associates Has Upped Its Medtronic Plc (MDT) Position by $822,400 as Stock Price Declined

May 23, 2018 - By Linda Rogers

Chevron Corporation (NYSE:CVX) Logo

First Financial Corp decreased its stake in Chevron Corporation (CVX) by 38.29% based on its latest 2017Q4 regulatory filing with the SEC. First Financial Corp sold 2,850 shares as the company’s stock declined 8.26% with the market. The institutional investor held 4,593 shares of the integrated oil company at the end of 2017Q4, valued at $575,000, down from 7,443 at the end of the previous reported quarter. First Financial Corp who had been investing in Chevron Corporation for a number of months, seems to be less bullish one the $243.67 billion market cap company. The stock decreased 0.56% or $0.72 during the last trading session, reaching $127.51. About 2.78 million shares traded. Chevron Corporation (NYSE:CVX) has risen 7.88% since May 23, 2017 and is uptrending. It has underperformed by 3.67% the S&P500.

Armstrong Henry H Associates Inc increased its stake in Medtronic Plc (MDT) by 5.57% based on its latest 2017Q4 regulatory filing with the SEC. Armstrong Henry H Associates Inc bought 10,280 shares as the company’s stock declined 4.15% with the market. The institutional investor held 194,837 shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $15.73M, up from 184,557 at the end of the previous reported quarter. Armstrong Henry H Associates Inc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $115.65 billion market cap company. The stock increased 0.42% or $0.36 during the last trading session, reaching $85.33. About 2.73M shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since May 23, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.10, from 1.12 in 2017Q3. It fall, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. Butensky & Cohen Fin Security reported 20,154 shares stake. Pillar Pacific Capital Mgmt Ltd Company reported 71,540 shares. Menora Mivtachim Hldgs Limited holds 457,655 shares. Gam Hldgs Ag holds 0.18% of its portfolio in Medtronic plc (NYSE:MDT) for 73,153 shares. Intact Invest Mgmt invested 0.04% of its portfolio in Medtronic plc (NYSE:MDT). Capital Intll holds 0.4% or 4.43M shares in its portfolio. Oakbrook Invests has 1.88% invested in Medtronic plc (NYSE:MDT) for 365,736 shares. Art Advsrs Limited Co invested in 28,600 shares or 0.1% of the stock. 4,745 were reported by Ballentine Ltd. Alpine Woods Capital Limited Com has 0.63% invested in Medtronic plc (NYSE:MDT) for 156,600 shares. Martin Inc Tn holds 0.56% or 22,016 shares in its portfolio. Alliancebernstein Lp holds 4.83 million shares or 0.28% of its portfolio. Loring Wolcott And Coolidge Fiduciary Advisors Ltd Liability Partnership Ma reported 5,945 shares or 0.01% of all its holdings. De Burlo Group Inc Incorporated stated it has 6,247 shares. Miller Investment Mngmt Lp holds 0.62% of its portfolio in Medtronic plc (NYSE:MDT) for 25,165 shares.

More important recent Medtronic plc (NYSE:MDT) news were published by: Investingnews.com which released: “New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti …” on May 23, 2018, also Globenewswire.com published article titled: “Medtronic Announces 2018 Institutional Investor and Analyst Meeting and Webcast”, Benzinga.com published: “Benzinga Pro’s 5 Stocks To Watch Today” on May 23, 2018. More interesting news about Medtronic plc (NYSE:MDT) was released by: Seekingalpha.com and their article: “Medtronic Should Focus On Aggressive Deleveraging” with publication date: May 15, 2018.

Among 29 analysts covering Medtronic (NYSE:MDT), 19 have Buy rating, 0 Sell and 10 Hold. Therefore 66% are positive. Medtronic had 83 analyst reports since August 10, 2015 according to SRatingsIntel. Deutsche Bank maintained Medtronic plc (NYSE:MDT) on Monday, July 31 with “Buy” rating. Jefferies maintained Medtronic plc (NYSE:MDT) on Wednesday, August 23 with “Buy” rating. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”. As per Wednesday, February 22, the company rating was maintained by Needham. SunTrust initiated Medtronic plc (NYSE:MDT) on Monday, April 25 with “Buy” rating. Needham maintained it with “Buy” rating and $95.0 target in Tuesday, November 21 report. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Oppenheimer on Tuesday, July 18. Needham maintained Medtronic plc (NYSE:MDT) on Tuesday, June 7 with “Buy” rating. The firm earned “Buy” rating on Friday, May 26 by Oppenheimer. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Tuesday, November 21 by Jefferies.

More notable recent Chevron Corporation (NYSE:CVX) news were published by: Seekingalpha.com which released: “Chevron Impresses In The Permian” on May 11, 2018, also Seekingalpha.com with their article: “Chevron: A Dividend Stock I’ll Never Buy” published on May 17, 2018, Investorplace.com published: “Use Cautious Optimism With Chevron Corporation Stock Right Now” on May 15, 2018. More interesting news about Chevron Corporation (NYSE:CVX) were released by: 247Wallst.com and their article: “Crude Oil Price Falls on Huge Inventory Increase” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “Chevron 2018 Turns Into A Cash Machine” with publication date: May 03, 2018.

Among 35 analysts covering Chevron Corporation (NYSE:CVX), 26 have Buy rating, 0 Sell and 9 Hold. Therefore 74% are positive. Chevron Corporation had 122 analyst reports since August 4, 2015 according to SRatingsIntel. On Wednesday, March 9 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The firm has “Neutral” rating by UBS given on Monday, August 3. Macquarie Research upgraded the stock to “Outperform” rating in Monday, December 21 report. RBC Capital Markets maintained Chevron Corporation (NYSE:CVX) on Tuesday, September 19 with “Sell” rating. As per Tuesday, October 24, the company rating was maintained by Cowen & Co. The stock of Chevron Corporation (NYSE:CVX) earned “Outperform” rating by Wolfe Research on Wednesday, March 9. RBC Capital Markets maintained the shares of CVX in report on Friday, April 13 with “Hold” rating. The firm earned “Neutral” rating on Monday, November 2 by Credit Suisse. The company was downgraded on Thursday, January 21 by Simmons & Co. The firm earned “Sell” rating on Friday, October 27 by RBC Capital Markets.

Since April 17, 2018, it had 0 insider purchases, and 8 insider sales for $48.52 million activity. Geagea Joseph C sold $1.56 million worth of Chevron Corporation (NYSE:CVX) on Friday, May 11. Yarrington Patricia E sold $17.55 million worth of stock or 135,000 shares. The insider Wirth Michael K sold 130,000 shares worth $16.64 million. Pate R. Hewitt also sold $3.11 million worth of Chevron Corporation (NYSE:CVX) on Tuesday, April 17.

Chevron Corporation (NYSE:CVX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: